Oral Wegovy, also made by Novo Nordisk, became available for weight loss in early 2026, and Novo plans to soon release a pill form of Ozempic
Heres the one-sentence summary: IGF-1 DES (des(1-3)IGF-1) is a truncated analog of insulin-like growth factor-1 thats been modified to eliminate its first three amino acids, making it roughly 10 times more potent than regular IGF-1 at the tissue level with a drastically shorter half-life of about 20-30 minutes
The more vials per order, the lower the per-vial cost
They are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind
Suppliers publishing openly, including Protide Health, Core Peptides, Sports Technology Labs, Biotech Peptides, BioLongevity Labs, and Simple Peptide, allow a comparison to happen before any commitment
Shiloach J, Kaufman J, Guillard AS, Fass R